He Qing-Hua, Zhou Ying-Sheng, Wang Zheng, Wang Shu, Mou Zhong-Qing, Li Jian, Chi Jia-Min
Department of Endocrinology, Beijing Hospital, Ministry of Health, Beijing 100730, China.
Zhonghua Yi Xue Za Zhi. 2008 Feb 5;88(6):374-7.
To investigate the effects of intervention against glucotoxicity on improvement of the function and pathological changes of islet beta and alpha cells.
Thirty-six male Sprague Dawley rats were randomly divided into four equal groups: normal control (NC) group, fed with standard chow, high-fat (HF) group, fed with extra high-fat chow; diabetes mellitus (DM) control group, fed with high-fat chow for 8 weeks followed by 30 mg/kg streptozotocin injection to establish DM models; and insulin (INS) group, treated with subcutaneous injection of long-acting insulin (glargine, 0.5 U x kg(-1) x d(-1)) for 4 weeks after the establishment of DM models. 48 h, 2 weeks, and 4 weeks after the STZ injection to the 2 DM groups oral glucose tolerance test (OGTT) was performed to all rats. Peripheral blood samples were collected from the caudal vein. Serum insulin level was assayed by radioimmunoassay. Total serum cholesterol (TC) and triglyceride (TG) were measured by enzyme-colorimetric method. By the end of experiment the rats were killed with their pancreases taken out. Immunohistochemistry was used to observe the morphological changes of the islet beta and alpha cells. Beta cell and alpha cell masses were calculated by the proportions of positive area in the islet. Proinsulin mRNA level was detected by RT-PCR. Insulin protein content in islets was detected by Western blotting.
Four weeks after the insulin intervention against glucotoxicity, the fasting blood glucose and blood glucose 2 h after sugar-taking of the INS group were both significantly lower than those of the DM group (both P < 0.01). The relative beta cell mass of the INS group was 0.38 +/- 0.08, significantly bigger, 2.45 times, that of the DM group (0.11 +/- 0.05, P < 0.01). The relative alpha cells mass in islets of the INS group was 0.16 +/- 0.04, significantly lower, by 43%, than that of the DM group (0.28 +/- 0.15, P < 0.01). The insulin contents in beta cells of the INS group was 0.58 +/- 0.03, significantly higher, by 70.6%, than that of the DM group (0.34 +/- 0.14, P < 0.01). The proinsulin mRNA level of the INS group was 1.52 +/- 0.14, significantly higher, by 20.6%, than that of the DM group.
The morphology of islet beta, alpha cells in diabetic rats was improved by four weeks of Intervention against glucotoxicity improves the pathology of islet beta and alpha cells in diabetic and insulin synthesis.
探讨干预糖毒性对改善胰岛β细胞和α细胞功能及病理变化的影响。
将36只雄性Sprague Dawley大鼠随机分为四组,每组9只:正常对照组(NC组),给予标准饲料;高脂组(HF组),给予高脂饲料;糖尿病对照组(DM组),给予高脂饲料8周后腹腔注射链脲佐菌素30 mg/kg建立糖尿病模型;胰岛素组(INS组),糖尿病模型建立后皮下注射长效胰岛素(甘精胰岛素,0.5 U·kg⁻¹·d⁻¹)4周。对2个糖尿病组大鼠在注射链脲佐菌素后48h、2周和4周进行口服葡萄糖耐量试验(OGTT)。从尾静脉采集外周血样本。采用放射免疫法测定血清胰岛素水平。采用酶比色法测定血清总胆固醇(TC)和甘油三酯(TG)。实验结束时处死大鼠,取出胰腺。采用免疫组织化学法观察胰岛β细胞和α细胞的形态变化。根据胰岛中阳性区域的比例计算β细胞和α细胞团块。采用RT-PCR检测胰岛素原mRNA水平。采用蛋白质免疫印迹法检测胰岛中胰岛素蛋白含量。
胰岛素干预糖毒性4周后,INS组空腹血糖及糖负荷后2 h血糖均显著低于DM组(均P<0.01)。INS组相对β细胞团块为0.38±0.08,显著大于DM组(0.11±0.05),为DM组的2.45倍(P<0.01)。INS组胰岛中相对α细胞团块为0.16±0.04,显著低于DM组(P<0.01),比DM组降低43%。INS组β细胞中胰岛素含量为0.58±0.03,显著高于DM组(P<0.01),比DM组高70.6%。INS组胰岛素原mRNA水平为1.52±0.14,显著高于DM组,比DM组高20.6%。
干预糖毒性4周可改善糖尿病大鼠胰岛β细胞、α细胞形态,改善糖尿病时胰岛β细胞和α细胞病理及胰岛素合成。